An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma

In lung adenocarcinoma (LUAD), immune heterogeneity of hot and cold tumors has been recognized as one of the major factors affecting immunotherapy and other common treatments. However, there is still a lack of biomarkers that can effectively identify the immunophenotype of cold and hot tumors. First...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tao, Liu, Yafeng, Wu, Jing, Bai, Ying, Zhou, Jiawei, Hu, Chunxiao, Zhang, Wenting, Guo, Jianqiang, Wang, Qingsen, Hu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060209/
https://www.ncbi.nlm.nih.gov/pubmed/36991102
http://dx.doi.org/10.1038/s41598-023-32276-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060209/
https://www.ncbi.nlm.nih.gov/pubmed/36991102
http://dx.doi.org/10.1038/s41598-023-32276-2

Ejemplares similares